即將上市(暗盤交易時(shí)段:今日16:15-18:30)
| 公司名稱▼
/
代號(hào)▼ | 行業(yè) | 招股價(jià) | 每手股數(shù) | 入場費(fèi) | 招股截止日 | 暗盤日期▼ | 上市日期▲ |
|
同業(yè)比較 - 生物科技- 用品與服務(wù)
公司名稱/代號(hào) | 現(xiàn)價(jià)2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權(quán)益 回報(bào)率(%)▼ | 經(jīng)營 利潤率(%)▼ | 總債項(xiàng)/ 股東權(quán)益(%)▼ | 選擇比較 |
藥明康德 02359.HK | 73.200 | +3.463% | +11.50% | 283.34億 | 21.23 | 3.39 | 41.583% | 1,595.00% | 2,922.00% | 1,450.00% | |
百濟(jì)神州 06160.HK | 162.400 | +4.036% | +13.25% | 2,499.85億 | N/A | 8.69 | N/A | -1,935.00% | -1,399.00% | 685.00% | |
藥明生物 02269.HK | 26.000 | +5.477% | +12.55% | 1,057.86億 | 29.74 | 2.40 | N/A | 803.00% | 2,673.00% | 1,181.00% | |
金斯瑞生物科技 01548.HK | 16.980 | +16.142% | +41.50% | 369.68億 | 1.57 | 1.09 | N/A | 6,854.00% | 28,270.00% | 395.00% | |
再鼎醫(yī)藥 09688.HK | 29.700 | +0.169% | +27.19% | 327.68億 | N/A | 4.98 | N/A | -3,057.00% | -6,387.00% | 1,825.00% | |
亞盛醫(yī)藥-B 06855.HK | 58.850 | +6.227% | +21.72% | 205.08億 | N/A | 66.03 | N/A | -15,346.00% | -3,370.00% | 63,154.00% | |
雲(yún)頂新耀 01952.HK | 54.550 | +14.481% | +29.27% | 178.32億 | N/A | 4.11 | N/A | -2,557.00% | -14,422.00% | 1,349.00% | |
康諾亞-B 02162.HK | 49.600 | +3.766% | +24.16% | 138.75億 | N/A | 5.27 | N/A | -2,082.00% | -11,327.00% | 3,044.00% | |
科濟(jì)藥業(yè)-B 02171.HK | 19.700 | +2.604% | -7.08% | 113.42億 | N/A | 10.02 | N/A | -7,553.00% | -200,906.00% | 1,575.00% | |
榮昌生物 09995.HK | 46.200 | +0.435% | +0.43% | 96.36億 | N/A | 11.91 | N/A | -7,393.00% | -8,162.00% | 13,445.00% | |
來凱醫(yī)藥-B 02105.HK | 22.150 | +13.823% | +27.15% | 90.31億 | N/A | 10.55 | N/A | -3,160.00% | N/A | 1,296.00% | |
腦動(dòng)極光-B 06681.HK | 7.000 | +1.892% | +2.34% | 88.64億 | N/A | N/A | N/A | -4,277.00% | -14,433.00% | N/A | |
樂普生物-B 02157.HK | 5.130 | +0.588% | +23.91% | 84.97億 | N/A | 11.74 | N/A | -5,853.00% | -10,462.00% | 11,954.00% | |
錦欣生殖 01951.HK | 3.080 | +4.407% | +14.50% | 84.54億 | 27.43 | 0.77 | N/A | 276.00% | 1,580.00% | 2,535.00% | |
歌禮製藥-B 01672.HK | 8.200 | +7.190% | +27.33% | 79.02億 | N/A | 3.81 | N/A | -1,531.00% | -2,302,564.00% | 39.00% | |
歐康維視生物-B 01477.HK | 9.150 | +19.452% | +32.99% | 74.47億 | N/A | 1.86 | N/A | -711.00% | -6,352.00% | 68.00% | |
和譽(yù)-B 02256.HK | 10.380 | +8.238% | +24.31% | 69.96億 | 218.53 | 3.39 | N/A | 145.00% | 1,580.00% | 124.00% | |
和鉑醫(yī)藥-B 02142.HK | 8.330 | +4.648% | -0.83% | 68.99億 | 296.44 | 6.59 | N/A | 223.00% | 1,901.00% | 4,929.00% | |
基石藥業(yè)-B 02616.HK | 4.250 | +8.696% | +16.76% | 57.99億 | N/A | 14.11 | N/A | -2,507.00% | -1,867.00% | 9,783.00% | |
康龍化成 03759.HK | 16.280 | +5.714% | +18.31% | 47.91億 | 15.11 | 1.99 | 19.736% | 1,317.00% | 2,003.00% | 4,388.00% | |
康希諾生物 06185.HK | 35.500 | +2.601% | +8.90% | 47.10億 | N/A | 1.68 | N/A | -772.00% | -3,689.00% | 4,101.00% | |
|